-
2
-
-
0141858282
-
Prognostic factors: Principles and application
-
Gospodarowicz MK, Henson, Hutter RVP, O'Sullivan B, Sobin LH, Wittekind Ch, editors. New York: Wiley-Liss
-
Gospodarowicz MK, O'Sullivan B. Prognostic factors: principles and application. In: Gospodarowicz MK, Henson, Hutter RVP, O'Sullivan B, Sobin LH, Wittekind Ch, editors. Prognostic factors in cancer, 2nd ed. New York: Wiley-Liss; 2001. p. 17-35.
-
(2001)
Prognostic Factors in Cancer, 2nd Ed.
, pp. 17-35
-
-
Gospodarowicz, M.K.1
O'Sullivan, B.2
-
3
-
-
0028070813
-
Increasing the power of surrogate endpoint biomarkers: The aggregation of predictive factors
-
Burke HB. Increasing the power of surrogate endpoint biomarkers: the aggregation of predictive factors. J Cell Biochem Suppl 1994;19:278-82.
-
(1994)
J Cell Biochem Suppl
, vol.19
, pp. 278-282
-
-
Burke, H.B.1
-
4
-
-
0027235762
-
Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients
-
Gasparini G, Pozza F, Harris AL. Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J Natl Cancer Inst 1993;85:1206-19.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 1206-1219
-
-
Gasparini, G.1
Pozza, F.2
Harris, A.L.3
-
5
-
-
0032412818
-
The relationship between prognostic and predictive factors in the management of breast cancer
-
Henderson IC, Patek AJ. The relationship between prognostic and predictive factors in the management of breast cancer. Breast Cancer Res Treat 1998;52:261-88.
-
(1998)
Breast Cancer Res Treat
, vol.52
, pp. 261-288
-
-
Henderson, I.C.1
Patek, A.J.2
-
6
-
-
0003276406
-
Tumors of the male sex organs
-
series 1, fascicle 32. Washington D.C.: Armed Forces Institute of Pathology
-
Dixon FJ, Moore RA. Tumors of the male sex organs. Atlas of tumor pathology, series 1, fascicle 32. Washington D.C.: Armed Forces Institute of Pathology; 1952. p. 10.
-
(1952)
Atlas of Tumor Pathology
, pp. 10
-
-
Dixon, F.J.1
Moore, R.A.2
-
7
-
-
22144438214
-
Hormone therapy and prostate cancer
-
Whitmore WF Jr. Hormone therapy and prostate cancer. Am J Med 1956;697:613.
-
(1956)
Am J Med
, vol.697
, pp. 613
-
-
Whitmore Jr., W.F.1
-
8
-
-
0016466084
-
The present status of radical prostatectomy for stage a and B prostate cancer
-
Jewett HJ. The present status of radical prostatectomy for stage A and B prostate cancer. Urol Clin North Am 1975;2:105-24.
-
(1975)
Urol Clin North Am
, vol.2
, pp. 105-124
-
-
Jewett, H.J.1
-
10
-
-
84900367176
-
Squamous cell epithelioma of the lip
-
Broders AC. Squamous cell epithelioma of the lip. JAMA 1920;74:656-64.
-
(1920)
JAMA
, vol.74
, pp. 656-664
-
-
Broders, A.C.1
-
12
-
-
0038541172
-
Carcinoma of the prostate
-
Muir EG. Carcinoma of the prostate. Lancet 1934;i:667-72.
-
(1934)
Lancet
, vol.1
, pp. 667-672
-
-
Muir, E.G.1
-
14
-
-
0016608092
-
Grading of prostate carcinoma
-
Mostofi FK. Grading of prostate carcinoma. Cancer Chemother Rep 1975;59:111-7.
-
(1975)
Cancer Chemother Rep
, vol.59
, pp. 111-117
-
-
Mostofi, F.K.1
-
16
-
-
0013890366
-
Classification of prostatic carcinoma
-
Gleason DF. Classification of prostatic carcinoma. Cancer Chemother Rep 1966;50:125-8.
-
(1966)
Cancer Chemother Rep
, vol.50
, pp. 125-128
-
-
Gleason, D.F.1
-
17
-
-
0014051456
-
The histology and prognosis of prostatic cancer
-
Mellinger GT, Gleason D, Bailar J III. The histology and prognosis of prostatic cancer. J Urol 1967;97:331-7.
-
(1967)
J Urol
, vol.97
, pp. 331-337
-
-
Mellinger, G.T.1
Gleason, D.2
Bailar III, J.3
-
18
-
-
0001916430
-
Histologic grading and clinical staging of prostatic carcinoma
-
Tannenbaum M, editor. Philadelphia, PA: Lea & Febiger
-
Gleason DF, Veterans Administration Cooperative Urological Research Group. Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M, editor. Urologic pathology: the prostate. Philadelphia, PA: Lea & Febiger; 1977. p. 171-97.
-
(1977)
Urologic Pathology: The Prostate
, pp. 171-197
-
-
Gleason, D.F.1
-
19
-
-
0001625949
-
Tumors of the prostate gland, seminal vesicles, male urethra, and penis
-
3rd series, fascicle 28. Washington D.C.: American Registry of Pathology
-
Young RH, Srigley JR, Amin MB, et al. Tumors of the prostate gland, seminal vesicles, male urethra, and penis. Atlas of tumor pathology, 3rd series, fascicle 28. Washington D.C.: American Registry of Pathology; 2000.
-
(2000)
Atlas of Tumor Pathology
-
-
Young, R.H.1
Srigley, J.R.2
Amin, M.B.3
-
20
-
-
17644397285
-
Pathology and genetics. Tumors of the urinary system and male genital organs
-
Lyon, France: IARC Press
-
Eble JN, Sauter G, Epstein JI, et al. Pathology and genetics. Tumors of the urinary system and male genital organs. WHO classification of tumors. Lyon, France: IARC Press; 2004.
-
(2004)
WHO Classification of Tumors
-
-
Eble, J.N.1
Sauter, G.2
Epstein, J.I.3
-
21
-
-
0033859846
-
Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland: A basis for checklists
-
Srigley JR, Amin MB, Bostwick DG, et al. Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland: a basis for checklists. Arch Pathol Lab Med 2000;124:1034-9.
-
(2000)
Arch Pathol Lab Med
, vol.124
, pp. 1034-1039
-
-
Srigley, J.R.1
Amin, M.B.2
Bostwick, D.G.3
-
22
-
-
3042705639
-
-
Philadelphia, PA: Lippincott, Williams and Wilkins
-
Amin MB, Grignon DJ, Humphrey PA, et al. Gleason grading of prostate cancer. A contemporary approach. Philadelphia, PA: Lippincott, Williams and Wilkins; 2004.
-
(2004)
Gleason Grading of Prostate Cancer. A Contemporary Approach
-
-
Amin, M.B.1
Grignon, D.J.2
Humphrey, P.A.3
-
23
-
-
0026548628
-
Prostate-specific antigen and other prognostic factors in patients with hormone-resistant prostatic cancer undergoing experimental treatment
-
Fossa SD, Paus E, Lindegaard M, et al. Prostate-specific antigen and other prognostic factors in patients with hormone-resistant prostatic cancer undergoing experimental treatment. Br J Urol 1992;69:175-9.
-
(1992)
Br J Urol
, vol.69
, pp. 175-179
-
-
Fossa, S.D.1
Paus, E.2
Lindegaard, M.3
-
24
-
-
0028153027
-
Prognostic factors in stage D2 prostate cancer; important implications for future trials: Results of a cooperative intergroup study (INT.0036)
-
The National Cancer Institute Intergroup Study #0036
-
Eisenberger MA, Crawford ED, Wolf M, et al. Prognostic factors in stage D2 prostate cancer; important implications for future trials: results of a cooperative intergroup study (INT.0036). The National Cancer Institute Intergroup Study #0036. Semin Oncol 1994;21:613-9.
-
(1994)
Semin Oncol
, vol.21
, pp. 613-619
-
-
Eisenberger, M.A.1
Crawford, E.D.2
Wolf, M.3
-
25
-
-
0030926567
-
Prognostic significance of prostate-specific antigen in stage Tie prostate cancer treated by radical prostatectomy
-
Cookson MS, Fleshner NE, Soloway SM, et al. Prognostic significance of prostate-specific antigen in stage Tie prostate cancer treated by radical prostatectomy. Urology 1997;49:887-97.
-
(1997)
Urology
, vol.49
, pp. 887-897
-
-
Cookson, M.S.1
Fleshner, N.E.2
Soloway, S.M.3
-
26
-
-
0030907162
-
Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: The basis for an adjuvant therapy trial
-
D'Amico AV, Whittington R, Malkowicz SB, et al. Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trial. J Clin Oncol 1997;15:1465-9.
-
(1997)
J Clin Oncol
, vol.15
, pp. 1465-1469
-
-
D'Amico, A.V.1
Whittington, R.2
Malkowicz, S.B.3
-
27
-
-
0030913315
-
Combination of prostate specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer
-
Partin AW, Nathan MW, Subong ENP. Combination of prostate specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer. JAMA 1997;277:145-51.
-
(1997)
JAMA
, vol.277
, pp. 145-151
-
-
Partin, A.W.1
Nathan, M.W.2
Subong, E.N.P.3
-
28
-
-
0030906817
-
Consensus statement: Guidelines for PSA following radiation therapy
-
American Society of Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:1035-41.
-
(1997)
Int J Radiat Oncol Biol Phys
, vol.37
, pp. 1035-1041
-
-
-
29
-
-
0032839364
-
PSA-based outcome analysis after radiation therapy for prostate cancer: A new definition of biochemical failure after intervention
-
Jani AB, Chen MH, Vaida F, et al. PSA-based outcome analysis after radiation therapy for prostate cancer: a new definition of biochemical failure after intervention. Urology 1999;554:700-5.
-
(1999)
Urology
, vol.554
, pp. 700-705
-
-
Jani, A.B.1
Chen, M.H.2
Vaida, F.3
-
30
-
-
0033253970
-
Post-treatment PSA ≤0.2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniques
-
Critz FA, Williams WH, Holladay CT, et al. Post-treatment PSA ≤0.2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniques. Urology 1999;54:968-71.
-
(1999)
Urology
, vol.54
, pp. 968-971
-
-
Critz, F.A.1
Williams, W.H.2
Holladay, C.T.3
-
31
-
-
0032774409
-
PSA decline is an independent prognostic marker in hormonally treated prostate cancer
-
Palmberg C, Koivisto P, Visakorpi T, et al. PSA decline is an independent prognostic marker in hormonally treated prostate cancer. Eur Urol 1999;36:191-6.
-
(1999)
Eur Urol
, vol.36
, pp. 191-196
-
-
Palmberg, C.1
Koivisto, P.2
Visakorpi, T.3
-
32
-
-
0028324389
-
Early androgen ablation for stage D1 (N1T0N3,M0) prostate cancer: Prognostic variable and outcome
-
Zagars GK, Sands ME, Pollack A, et al. Early androgen ablation for stage D1 (N1T0N3,M0) prostate cancer: prognostic variable and outcome. J Urol 1999;151:1330-3.
-
(1999)
J Urol
, vol.151
, pp. 1330-1333
-
-
Zagars, G.K.1
Sands, M.E.2
Pollack, A.3
-
33
-
-
0033451682
-
Predictive factors in prostate cancer: Current concepts from the 1999 College of American Pathologists Conference on Solid Tumor Prognostic Factors and the 1999 World Health Organization Second International Consultation on Prostate Cancer
-
Bostwick DG, Foster CS. Predictive factors in prostate cancer: current concepts from the 1999 College of American Pathologists Conference on Solid Tumor Prognostic Factors and the 1999 World Health Organization Second International Consultation on Prostate Cancer. Semin Urol Oncol 1999;17:222-72.
-
(1999)
Semin Urol Oncol
, vol.17
, pp. 222-272
-
-
Bostwick, D.G.1
Foster, C.S.2
-
34
-
-
12944332009
-
Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999
-
Bostwick DG, Grignon DG, Hammond EH, et al. Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:995-1000.
-
(2000)
Arch Pathol Lab Med
, vol.124
, pp. 995-1000
-
-
Bostwick, D.G.1
Grignon, D.G.2
Hammond, E.H.3
-
35
-
-
0015950349
-
The Veterans Administration Cooperative Urological Research Group: Prediction of prognosis for prostatic carcinoma by combined histological grading and clinical staging
-
Gleason DF, Mellinger GT. The Veterans Administration Cooperative Urological Research Group: prediction of prognosis for prostatic carcinoma by combined histological grading and clinical staging. J Urol 1974;111:58-64.
-
(1974)
J Urol
, vol.111
, pp. 58-64
-
-
Gleason, D.F.1
Mellinger, G.T.2
-
36
-
-
0027362788
-
Criteria for prognostic factors and for an enhanced prognostic system
-
Burke HB, Henson DE. Criteria for prognostic factors and for an enhanced prognostic system. Cancer 1993;72:3131-5.
-
(1993)
Cancer
, vol.72
, pp. 3131-3135
-
-
Burke, H.B.1
Henson, D.E.2
-
37
-
-
22144441251
-
Statistical methods for the analysis of prognostic factor studies
-
Gospodarowicz MK, Hensen DE, Hutter REP, et al., editors. New York: Wiley-Liss
-
McShane LM, Simon R. Statistical methods for the analysis of prognostic factor studies. In: Gospodarowicz MK, Hensen DE, Hutter REP, et al., editors. Prognostic factors in cancer, 2nd ed. New York: Wiley-Liss; 2001. p. 49-56.
-
(2001)
Prognostic Factors in Cancer, 2nd Ed.
, pp. 49-56
-
-
McShane, L.M.1
Simon, R.2
-
38
-
-
0034287457
-
Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer
-
Kattan MW, Zelefsky MJ, Kupelian PA, et al. Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol 2000;18:3352-9.
-
(2000)
J Clin Oncol
, vol.18
, pp. 3352-3359
-
-
Kattan, M.W.1
Zelefsky, M.J.2
Kupelian, P.A.3
-
39
-
-
0034872990
-
Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer
-
Kattan MW, Potters L, Blasko JC, et al. Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. Urology 2001;58:393-9.
-
(2001)
Urology
, vol.58
, pp. 393-399
-
-
Kattan, M.W.1
Potters, L.2
Blasko, J.C.3
-
40
-
-
0032550753
-
A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
-
Kattan MW, Eastham JA, Stapleton AMF, et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998;90:766-71.
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 766-771
-
-
Kattan, M.W.1
Eastham, J.A.2
Stapleton, A.M.F.3
-
41
-
-
0031047117
-
Artificial neural networks improve the accuracy of cancer survival prediction
-
Burke HB, Goodman PH, Rosen DB, et al. Artificial neural networks improve the accuracy of cancer survival prediction. Cancer 1997;79:857-62.
-
(1997)
Cancer
, vol.79
, pp. 857-862
-
-
Burke, H.B.1
Goodman, P.H.2
Rosen, D.B.3
-
42
-
-
22144435072
-
Diagnosis and prognostic parameters in localized prostate cancer
-
Diagnosis and prognostic parameters in localized prostate cancer. Scand J Urol Nephrol Suppl 1994;162:1-127.
-
(1994)
Scand J Urol Nephrol Suppl
, vol.162
, pp. 1-127
-
-
-
43
-
-
0029562716
-
College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors
-
Henson DE, Fielding LP, Grignon DJ, et al. College of American Pathologists Conference XXVI on Clinical Relevance of Prognostic Markers in Solid Tumors. Arch Pathol Lab Med 1995;119:1109-12.
-
(1995)
Arch Pathol Lab Med
, vol.119
, pp. 1109-1112
-
-
Henson, D.E.1
Fielding, L.P.2
Grignon, D.J.3
-
44
-
-
0029617845
-
College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors
-
Grignon DJ, Hammond EH. College of American Pathologists Conference XXVI on Clinical Relevance of Prognostic Markers in Solid Tumors. Arch Pathol Lab Med 1995;119:1122-6.
-
(1995)
Arch Pathol Lab Med
, vol.119
, pp. 1122-1126
-
-
Grignon, D.J.1
Hammond, E.H.2
-
45
-
-
0033854631
-
College of American Pathologists Conference XXXV: Solid tumor prognostic factors - Which, how and so what?
-
Hammond ME, Fitzgibbons PL, Compton CC, et al. College of American Pathologists Conference XXXV: Solid Tumor Prognostic Factors - Which, How and So What? Arch Pathol Lab Med 2000;124:958-65.
-
(2000)
Arch Pathol Lab Med
, vol.124
, pp. 958-965
-
-
Hammond, M.E.1
Fitzgibbons, P.L.2
Compton, C.C.3
-
46
-
-
0030036589
-
Current prognostic factors for prostate carcinoma
-
Montie JE. Current prognostic factors for prostate carcinoma. Cancer 1996;78:341-4.
-
(1996)
Cancer
, vol.78
, pp. 341-344
-
-
Montie, J.E.1
-
47
-
-
0029683042
-
Current prognostic factors and their relevance to staging
-
Hutter RVP, Montie JE, Busch D, et al. Current prognostic factors and their relevance to staging. Cancer 1996;78:369-71.
-
(1996)
Cancer
, vol.78
, pp. 369-371
-
-
Hutter, R.V.P.1
Montie, J.E.2
Busch, D.3
-
48
-
-
0030036082
-
Exploration of new pathologic factors in terms of potential for prognostic significance and future applications
-
Von Eschenbach AC, Brawer MK, di Sant'Agnese A, et al. Exploration of new pathologic factors in terms of potential for prognostic significance and future applications. Cancer 1996;78:372-5.
-
(1996)
Cancer
, vol.78
, pp. 372-375
-
-
Von Eschenbach, A.C.1
Brawer, M.K.2
Di Sant'Agnese, A.3
-
51
-
-
5444263006
-
Evidence-based medicine, medical decision analysis, and pathology
-
Marchevsky AM, Wick MR. Evidence-based medicine, medical decision analysis, and pathology. Hum Pathol 2004;35:1179-88.
-
(2004)
Hum Pathol
, vol.35
, pp. 1179-1188
-
-
Marchevsky, A.M.1
Wick, M.R.2
|